The pharmacology of McN-A-343

Pharmacology and Therapeutics

Volumn 135, Issue 2, 2012, Pages 216-245

  Mitchelson, Frederick J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Allosteric; Bitopic agonist; McN A 343; Muscarinic acetylcholine receptors; Partial agonist

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; DARIFENACIN; EMETIC AGENT; GALLAMINE; GLUCAGON LIKE PEPTIDE 1; METHOCTRAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; NEUROPEPTIDE Y; NIFEDIPINE; OTENZEPAD; OXOTREMORINE; PILOCARPINE; PIRENZEPINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST; VERAPAMIL;

ALLOSTERISM; ANESTHESIA; BINDING SITE; BLOOD PRESSURE; BRADYCARDIA; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; HEART MUSCLE CONTRACTILITY; HUMAN; LEARNING DISORDER; LONG TERM POTENTIATION; MEMORY DISORDER; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REVIEW; SMOOTH MUSCLE; SYMPATHETIC GANGLION; TACHYCARDIA; TISSUE REACTION; VASCULAR TISSUE; VASOCONSTRICTION;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; ANIMALS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; ENDOCRINE GLANDS; HUMANS; MUSCARINIC AGONISTS; MUSCLE, SMOOTH; PERIPHERAL NERVOUS SYSTEM;

EID: 84862689161     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.05.008     Document Type: Review

References (359)

1. Adami, M., Bertaccini, G., Coruzzi, G., & Poli, E. (1985). Characterization of cholinoreceptors in the rat urinary bladder by the use of agonists and antagonists of the cholinergic system. J Auton Pharmacol 5, 197-205.
2. Akasu, T. (1992). Synaptic transmission and modulation in parasympathetic ganglia. Jpn J Physiol 42, 839-864.
3. Akasu, T., & Nishimura, T. (1995). Synaptic transmission and function of parasympathetic ganglia. Prog Neurobiol 45, 459-522.
4. Akiba, I., Kubo, T., Maeda, A., Bujo, H., Nakai, J., Mishina, M., et al. (1988). Primary structure of porcine muscarinic acetylcholine receptor III and antagonist binding studies. FEBS Lett 235, 257-261.
5. 2+ mobilization by muscarinic agonists in tracheal smooth muscle. Am J Physiol 264, L53-L59
6. (Lung Cell Mol Physiol 8).
7. Alkadhi, K., Branisteanu, D. D., Henderson, E. G., Lambert, J. J., & Volle, R. L. (1980). Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog. Naunyn Schmiedebergs Arch Pharmacol 312, 117-121.
8. 3H-noradrenaline by guinea-pig atria. Br J Pharmacol 45, 480-489.
9. 3H-(±)-noradrenaline by guinea-pig atria. Br J Pharmacol 47, 179-180.
10. 3H]-noradrenaline from rabbit isolated ear arteries and guinea-pig atria. Br J Pharmacol 51, 29-34.
11. Ally, A., Hara, Y., & Murayama, S. (1993). Cardiovascular effects of central administration of cholinomimetics in anesthetized cats. Neuropharmacology 32, 185-193.
12. Alonso de la Sierra, B. G. (1962). Action of some ganglion-stimulating substances on the secretion of saliva from the submandibular gland. Br J Pharmacol 18, 501-509.
13. 3 receptors in cat cerebral arteries. Brain Res 567, 76-82.
14. Anini, Y., & Brubaker, P. L. (2003). Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology 144, 3244-3250.
15. Armstead, W. M., Mirro, R., Leffler, C. W., & Busija, D. W. (1988). Ach produces cerebro-vascular constriction through activation of muscarinic-1 receptors in the newborn pig. J Pharmacol Exp Ther 247, 926-933.
16. Baba, H., Kohno, T., Okamoto, M., Goldstein, P. A., Shimoji, K., & Yoshimura, M. (1998). Muscarinic facilitation of GABA release in substantia gelatinosa of the rat dorsal horn. J Physiol 508, 83-93.
17. Ballesta, J. J., Borges, R., Garcia, A. G., & Hidalgo, M. J. (1989). Secretory and radioligand binding studies on muscarinic receptors in bovine and feline chromaffin cells. J Physiol 418, 411-426.
18. Barahona, M. V., Sánchez-Fortún, S., San Andrés, M. D., Ballesteros, E., & San Andrés, M. (1997). Achsterase histochemistry and functional characterization of the muscarinic receptor mediating the contraction of the bovine oesophageal groove. J Auton Pharmacol 17, 77-86.
19. Barocelli, E., Chiavarini, M., Ballabeni, V., Bordi, F., & Impicciatore, M. (1993). Interaction of selective compounds with muscarinic receptors at dispersed intestinal smooth muscle cells. Br J Pharmacol 108, 393-397.
20. Barocelli, E., Morini, G., Ballabeni, V., Lavezzo, A., & Impicciatore, M. (1990). Effects of two new pirenzepine analogs on the contractile response of the guinea-pig oesophageal muscularis mucosae to Ach, bethanecol, histamine and high potassium. Eur J Pharmacol 179, 89-96.
21. Bartolini, A., Ghelardini, C., Fantetti, L., Malcangio, M., Malmberg-Aiello, P., & Giotti, A. (1992). Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 105, 77-82.
22. 1 mediation. Neuropharmacology 27, 949-956.
23. Beleslin, D. B., Strbac, M., Jovanovic-Micic, D., Samardzic, R., & Nedelkovski, V. (1989). Area postrema: cholinergic and noradrenergic regulation of emesis; a new concept. Arch Int Physiol Biochim 97, 107-115.
24. Bentley, G. A. (1972). Pharmacological studies on the hypogastric ganglion of the rat and guinea-pig. Br J Pharmacol 44, 492-509.
25. Bhagat, B. (1966). Response of isolated guinea-pig atria to various ganglion-stimulating agents. J Pharmacol Exp Ther 154, 264-270.
26. Bhattacharya, S. K., & Sen, A. P. (1992). Effects of muscarinic agonists and antagonists on rat brain serotonergic activity. J Neural Transm Gen Sect 90, 241-247.
27. Birdsall, N. J., Burgen, A. S., Hulme, E. C., Stockton, J. M., & Zigmond, M. J. (1983). The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br J Pharmacol 78, 257-259.
28. Black, J. W., & Shankley, N. P. (1985). Pharmacological analysis of the muscarinic receptors involved when McN-A-343 stimulates acid secretion in the mouse isolated stomach. Br J Pharmacol 86, 609-617.
29. Blankesteijn, W. M., Siero, H. L. M., Rodrigues de Miranda, J. F., van Megan, Y. J. B., & Russel, F. G. M. (1993). Characterization of muscarinic receptors in rat kidney. Eur J Pharmacol-Mol Pharmacol Sect 244, 21-27.
30. Boddeke, H. W. G. M. (1991). Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices. Eur J Pharmacol 201, 191-197.
31. 2y purinoceptors. J Auton Nerv Syst 81, 53-58.
32. 3 receptors are involved in the release of urinary bladder-derived relaxant factor. Pharmacol Res 59, 300-305.
33. Bradley, K.N. (1999). The in vitro effects of muscarinic toxins MT2, MT3, MT4 and MT7 isolated from the venom of Dendroaspis angusticeps. Ph.D. Thesis, University of Strathclyde, Glasgow, UK.
34. 1-adrenoceptors in the rabbit vas deferens preparation. Toxicon 39, 581-587.
35. Bräuner-Osborne, H., Ebert, B., Brann, M. R., Falch, E., & Krogsgaard-Larsen, P. (1996). Functional partial agonism at cloned human muscarinic Ach receptors. Eur J Pharmacol 313, 145-150.
36. Brown, D. A., Fatherazi, S., Garthwaite, J., & White, R. D. (1980). Muscarinic receptors in rat sympathetic ganglia. Br J Pharmacol 70, 577-592.
37. Buckley, N. J., Bonner, T. I., Buckley, C. M., & Brann, M. R. (1989). Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35, 469-476.
38. Budriesi, R., Cacciaguerra, S., Di Toro, R., Bolognesi, M. L., Chiarini, A., Minarini, A., et al. (2001). Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines. Br J Pharmacol 132, 1009-1016.
39. Buller, S., Zlotos, D. P., Mohr, K., & Ellis, J. (2002). Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands. Mol Pharmacol 61, 160-168.
40. Bungardt, E., Vockert, E., Feifel, R., Moser, U., Tacke, R., Mutschler, E., et al. (1992). Characterization of muscarinic receptors mediating vasodilation in guinea-pig ileum submucosal arterioles by the use of computer-assisted videomicroscopy. Eur J Pharmacol 213, 53-61.
41. Burgen, A. S. V., & Spero, L. (1968). The action of Ach and other drugs on efflux of potassium and rubidiumfrom smoothmuscle of the guinea-pig intestine. Br J Pharmacol 34, 99-115.
42. Burgen, A. S. V., & Spero, L. (1970). The effects of calcium and magnesium on the response of intestinal smooth muscle to drugs. Br J Pharmacol 40, 492-500.
43. Calabresi, P., Centonze, P., Gubellini, P., Pisani, A., & Bernardi, G. (1998). Endogenous Ach enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. Eur J Neurosci 10, 2887-2895.
44. Carey, H. V., Tien, X. -Y., Wallace, L. J., & Cooke, H. J. (1987). Muscarinic receptor sub-types mediating the mucosal response to neural stimulation of guinea pig ileum. Am J Physiol 253, G323-G329
45. (Gastrointest Liver Physiol 16).
46. 1 muscarinic cholinoceptors mediating facilitation of noradrenaline release in guinea-pig carotid artery. Naunyn Schmiedebergs Arch Pharmacol 346, 391-394.
47. Cembala, T. M., Sherwin, J. D., Tidmarsh, M. D., Appadu, B. L., & Lambert, D. G. (1998). Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 125, 1088-1094.
48. 4 receptor as an approach to treating schizophrenia. Proc Natl Acad Sci U S A 105, 10978-10983.
49. Chen, C., LeBlanc, C., & Bobbin, R. P. (1996). Differences in cholinergic responses from outer hair cells of rat and guinea pig. Hear Res 98, 9-17.
50. Chiba, S., Hashimoto, K., & Hashimoto, K. (1970). Effects of nicotine, DMPP and McN-A-343 administered into the AV node artery of the dog. Tohoku J Exp Med 100, 199-200.
51. Chiba, S., Hashimoto, K., Kubota, K., & Satoh, S. (1971). Blocking effect of McN-A-343 on cardiac slowing produced by vagal stimulation. Br J Pharmacol 43, 675-676.
52. Chiba, S., & Tsukada, M. (1991). Muscarinic receptor subtype in isolated dog and monkey facial vein. Jpn J Pharmacol 55, 291-293.
53. 3 receptor subtypes mediating vasodilation in isolated, perfused canine lingual arteries. Clin Exp Pharmacol Physiol 23, 839-843.
54. Choo, L. K., & Mitchelson, F. (1990). Selective inhibition of responses to Cch and McN-A-343 in the rabbit vas deferens. Clin Exp Pharmacol Physiol 17, 601-611.
55. Choo, L. K., Mitchelson, F., & Vong, Y. M. (1985). The interaction of McN-A-343 with pirenzepine and other selective muscarine receptor antagonists at a prejunctional muscarine receptor. Naunyn Schmiedebergs Arch Pharmacol 328, 430-438.
56. Choo, L. K., Mitchelson, F., & Vong, Y. M. (1986). Interaction of some muscarinic agonists and antagonists at the prejunctional muscarinic receptor in the rabbit ear artery preparation. Br J Pharmacol 87, 733-740.
57. Christ, D. (1979). Effects of nicotine and hexamethonium on discharges in the stellate ganglion. Eur J Pharmacol 54, 243-249.
58. Christ, D. (1980). Post-tetanic potentiation in ganglia which are blocked with hexamethonium. Br J Pharmacol 69, 249-255.
59. 2 receptors. Eur J Pharmacol 339, 153-156.
60. Coruzzi, G., Poli, E., & Bertaccini, G. (1985). Action of different agonists and antagonists of the cholinergic system on the rat lower oesophageal sphincter. Gen Pharmacol 16, 561-566.
61. Daniel, E. E., Jury, J., & Bowker, P. (1987). Muscarinic receptors on nerves and muscles in opossum esophagus muscularis mucosa. Can J Physiol Pharmacol 65, 1903-1907.
62. Daniel, E. E., Jury, J., & Rowbotham, K. H. (1986). Receptors for neurotransmitters in opossum oesophagus muscularis mucosa. Br J Pharmacol 88, 707-714.
63. 3 muscarine receptors. Naunyn Schmiedebergs Arch Pharmacol 345, 288-295.
64. Darroch, S. A., Gardner, A., Vong, Y. M., Choo, L. K., & Mitchelson, F. (1991). Effect of temperature reduction on responsiveness to cholinomimetics in the taenia caeci of the guinea-pig. J Auton Pharmacol 11, 109-119.
65. 3 pharmacology. Eur J Pharmacol 178, 203-213.
66. 1 receptors. J Pharm Pharmacol 53, 487-496.
67. Delgado-Garcia, J. M., Yajeya, J., & Navarro-Lopez, J. de D. (2006). A cholinergic mechanism underlies persistent neural activity necessary for eye fixation. Prog Brain Res 154, 211-224.
68. Dohanich, G. P., McMullan, D. M., Cada, D. A., & Mangum, K. A. (1991). Muscarinic receptor subtypes and sexual behaviour in female rats. Pharmacol Biochem Behav 38, 115-124.
69. Dong, G. Z., Kameyama, K., Rinken, A., & Haga, T. (1995). Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells. J Pharmacol Exp Ther 274, 378-384.
70. 3 receptors. J Pharmacol Exp Ther 242, 257-262.
71. Doods, H. N., Willim, K. D., Boddeke, H. W. G. M., & Entzeroth, M. (1993). Characterization of muscarinic receptors in guinea-pig uterus. Eur J Pharmacol 250, 223-230.
72. Dörje, F., Levey, A. I., & Brann, M. R. (1991a). Immunological detection of muscarinic subtype proteins (m1-m5) in rabbit peripheral tissues. Mol Pharmacol 40, 459-462.
73. Dörje, F., Rettenmayr, N. M., Mutschler, E., & Lambrecht, G. (1991b). Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens. Eur J Pharmacol 203, 417-420.
74. Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E., & Brann, M. R. (1991c). Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256, 727-733.
75. Duckles, S. P. (1988). Vascular muscarinic receptors: pharmacological characterization in the bovine coronary artery. J Pharmacol Exp Ther 246, 929-934.
76. Edwardson, J. M., & Szekeres, P. G. (1999). Endocytosis and recycling of muscarinic receptors. Life Sci 64, 487-494.
77. Eglen, R. M., Kenny, B. A., Michel, A. D., & Whiting, R. L. (1987). Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification. Br J Pharmacol 90, 693-700.
78. Eglen, R. M., Sharif, N. A., & To, Z. P. (1993). Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells. Eur J Pharmacol-Mol Pharmacol Sect 244, 49-55.
79. 3 muscarinic receptors in guinea pig ileum and transfected cells. J Pharmacol Exp Ther 289, 981-992.
80. Elgoyhen, A. B., Johnson, D. S., Boulter, J., Vetter, D. E., & Heinemann, S. (1994). α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79, 705-715.
81. Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001). α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci 98, 3501-3506.
82. Elnatan, A., & Mitchelson, F. (1993). The interaction of McN-A-343 with muscarinic receptors in cardiac and smooth muscle. Biochem Pharmacol 46, 993-1003.
83. 2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol 151, 205-221.
84. 2 receptor stimulation in rabbit vas deferens. Eur J Pharmacol 263, 31-37.
85. 1-type. Eur J Pharmacol 158, 233-242.
86. 4 receptors? Eur J Pharmacol 332, 77-87.
87. Eltze, M., Ullrich, B., Mutschler, E., Moser, U., Bungardt, E., Friebe, T., et al. (1993). Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eur J Pharmacol 238, 343-355.
88. 3 muscarinic receptors in the rat peripheral lung. Biochem Pharmacol 52, 643-658.
89. Expósito, I., Sanz, B., & Mora, F. (1997). M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum. Neurochem Res 22, 1485-1490.
90. Fernández, J. L., Rivera, L., López, P. G., Recio, P., Vela-Navarrete, R., & García-Sacristán, A. (1998). Characterization of the muscarinic receptor mediating contraction of the dog prostrate. J Auton Pharmacol 18, 205-211.
91. Fielden, R., Sutton, T. J., & Taylor, E. M. (1980). Effect of tilting on the pressor responses to McN-A-343, amuscarinic sympathetic ganglion stimulant. Br J Pharmacol 71, 287-295.
92. 4 muscarinic receptor subtypes. J Pharmacol Exp Ther 328, 331-342.
93. 1 muscarinic receptor using its nitrogen mustard derivative and Ach mustard. Br J Pharmacol 160, 1534-1549.
94. File, S. E., Kenny, P. J., & Cheeta, S. (2000). The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66, 65-72.
95. Flacke, W., & Fleisch, J. H. (1970). The effect of ganglionic agonists and antagonists on the cardiac sympathetic ganglia of the dog. J Pharmacol Exp Ther 174, 45-55.
96. Fox, J. E. T., Daniel, E. E., Jury, J., & Robotham, H. (1985). Muscarinic inhibition of canine small intestinal motility in vivo. Am J Physiol 248, G526-G531
97. (Gastrointest Liver Physiol 11).
98. Fozard, J. R., & Muscholl, E. (1972). Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Br J Pharmacol 45, 616-629.
99. Fozard, J. R., & Muscholl, E. (1974). Atropine-resistant effects of the muscarinic agonists McN-A-343 and AHR-602 on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Br J Pharmacol 50, 531-541.
100. Fuder, H., & Meincke, M. (1993). Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 347, 591-595.
101. Furukawa, K., Nabekura, J., & Akaike, N. (1994). Nicotinic and muscarinic Ach responses in differentiated PC12 cells. Brain Res 638, 302-310.
102. Gardner, A. L., Choo, L. K., & Mitchelson, F. (1988a). Comparison of the effects of some muscarinic agonists on smooth muscle function and phosphatidylinositol turnover in the guinea-pig taenia caeci. Br J Pharmacol 94, 199-211.
103. Gardner, A. L., Choo, L. K., & Mitchelson, F. (1988b). Paraoxon-induced desensitization and its reversal by tetrodotoxin. Gen Pharmacol 19, 583-588.
104. Garnier, M., Lamacz, M., Galas, L., Lenglet, S., Tonon, M. C., & Vaudry, H. (1998). Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia. Endocrinology 139, 3525-3533.
105. 1 receptors. Br J Pharmacol 129, 1633-1640.
106. Gilbert, R., Rattan, S., & Goyal, R. K. (1984). Pharmacologic identification, activation and antagonism of two muscarinic receptor subtypes in the lower esophageal sphincter. J Pharmacol Exp Ther 230, 284-291.
107. Gillberg, P. -G., Sundquist, S., & Nilvebrant, L. (1998). Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Eur J Pharmacol 349, 285-292.
108. Ginsborg, B. L. (1965). The actions of McN-A-343, pilocarpine and acetyl-β-methylcholine on sympathetic ganglion cells of the frog. J Pharmacol Exp Ther 150, 216-219.
109. Gitler, M. S., Reba, R. C., Cohen, V. I., Rzeszotarski, W. J., & Baumgold, J. (1992). A novel m2-selective muscarinic antagonist: binding characteristics and autoradiographic distribution in rat brain. Brain Res 582, 253-260.
110. González, J. C., Albiñana, E., Baldelli, P., García, A. G., & Hernández-Guijo, J. M. (2011). Presynaptic muscarinic receptor subtypes involved in the enhancement of spontaneous GABAergic postsynaptic currents in hippocampal neurons. Eur J Neurosci 33, 69-81.
111. Gregory, K. J., Hall, N. E., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2010). Identification of orthosteric and allosteric site mutations in M2 muscarinic Ach receptors that contribute to ligand-selective signaling bias. J Biol Chem 285, 7459-7474.
112. 15. J Pharmacol Exp Ther 321, 1193-1207.
113. 4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle. Naunyn Schmiedebergs Arch Pharmacol 356, 505-516.
114. 2+ sensitivity of contractile activation during muscarinic stimulation of tracheal muscle. Am J Physiol 263, C1258-C1265
115. (Cell Physiol 32).
116. Gunst, S. J., Stropp, J. Q., & Flavahan, N. A. (1989). Muscarinic receptor reserve and β-adrenergic sensitivity in tracheal smooth muscle. J Appl Physiol 67, 1294-1298.
117. Guo, J. -Z., & Chiappinelli, V. A. (2001). Distinct muscarinic receptors enhance spontaneous GABA release and inhibit electrically evoked GABAergic synaptic transmission in the chick lateral spiriform nucleus. Neuroscience 104, 1057-1066.
118. 2-muscarinic agonist-receptor interactions. Mol Pharmacol 37, 682-688.
119. 3 receptor stimulation in guinea-pig coronary artery. Br J Pharmacol 115, 717-722.
120. 1 muscarinic receptors. Auton Autacoid Pharmacol 26, 275-284.
121. 1 muscarinic Ach receptor. J Pharmacol Exp Ther 301, 129-137.
122. Harsing, L. G., Jr., & Zigmond, M. J. (1998). Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Res Bull 45, 607-613.
123. Harvey, A. L., Kornisiuk, E., Bradley, K. N., Cerveñansky, C., Durán, R., Adrover, M., et al. (2002). Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors. Neurochem Res 27, 1543-1554.
124. 3 muscarinic receptor subtype in rat dorsolateral septal nucleus neurons. J Neurophysiol 76, 2221-2230.
125. Heldman, E., Barg, J., Fisher, A., Levy, R., Pittel, Z., Zimlichman, R., et al. (1996). Pharmacological basis for functional selectivity of partial muscarinic receptor agonists. Eur J Pharmacol 297, 283-291.
126. 2-receptor subtypes for agonists and antagonists in porcine gastric smooth muscle and mucosa. Gastroenterology 94, 630-637.
127. Hernández, M., Simonsen, U., Prieto, D., Rivera, L., Garcia, P., Ordaz, E., et al. (1993). Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter. Br J Pharmacol 110, 1413-1420.
128. 2+-influx pathways in taenia caeci. Br J Pharmacol 122, 985-992.
129. ++ release pathways in smooth muscle of the guinea-pig taenia caeci. Clin Exp Pharmacol Physiol 34, 191-197.
130. Hobbiger, F., Mitchelson, F., & Rand, M. J. (1969). The actions of some cholinomimetic drugs on the isolated taenia of the guinea-pig caecum. Br J Pharmacol 36, 53-69.
131. Holman, M. E., Muir, T. C., Szurszewski, J. H., & Yonemura, K. (1971). Effects of iontophoretic application of cholinergic agonists and their antagonists to guinea-pig pelvic ganglia. Br J Pharmacol 44, 26-40.
132. Honda, K., Ando, S., Koga, K., & Takano, Y. (2004). The spinal muscarinic receptor subtypes contribute to the morphine-induced antinociceptive effects in thermal stimulation in mice. Neurosci Lett 371, 235-238.
133. A receptors contribute to the McN-A-343-induced antinociceptive effects during thermal stimulation of mice. J Pharmacol Sci 108, 472-479.
134. Hozumi, S., Nakagawasai, O., Tan-No, K., Niijima, F., Yamadera, F., Murata, A., et al. (2003). Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res 138, 9-15.
135. 1 muscarinic receptors. Mol Pharmacol 38, 895-903.
136. Hu, J., Wang, S. -Z., & El-Fakahany, E. E. (1991). Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 257, 938-945.
137. 1 muscarinic receptors. Br J Pharmacol 126, 735-745.
138. 2 muscarinic acetylcholine receptor: More similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl) ammonium]dibromide. Mol Pharmacol 68, 769-778.
139. Inan, S., Dun, N. J., & Cowan, A. (2011). Investigation of gastrin-releasing peptide as a mediator for 5′-guanidinonaltrindole- induced compulsive scratching in mice. Peptides 32, 286-292.
140. 1 receptor activation reduces maximum upstroke velocity of action potential in mouse right atria. Eur J Pharmacol 346, 227-236.
141. Islam, M. A., Nojima, H., & Kimura, I. (1998b). Ach-induced biphasic effect on the maximum upstroke velocity of action potential in mouse right atria: interaction with β-adrenergic signaling cascade. Jpn J Pharmacol 78, 181-190.
142. Jaiswal, N., Jaismal, R. K., & Malik, K. U. (1991a). Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells. Mol Pharmacol 40, 101-106.
143. Jaiswal, N., Lambrecht, G., Mutschler, E., Tacke, R., & Malik, K. U. (1991b). Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J Pharmacol Exp Ther 258, 842-850.
144. 2β muscarinic receptors in the rabbit aorta. Prostaglandins 39, 267-280.
145. Jakubík, J., Baèáková, L., El-Fakahany, E. E., & Tuèek, S. (1997). Positive cooperativity of Ach and other agonists with allosteric ligands on muscarinic Ach receptors. Mol Pharmacol 52, 172-179.
146. Jánossy, A., Orsó, E., Szalay, K. Sz., Jurányi, Z., Beck, M., Vizi, E. S., et al. (1998). Cholinergic regulation of the rat adrenal zona glomerulosa. J Endocrinol 157, 305-315.
147. Jaramillo, J., & Volle, R. L. (1967). Nonmuscarinic stimulation and block of a sympathetic ganglion by 4-(m-chlorophenylcarbamoyloxy)-2- butynyltrimethyl-ammonium chloride (McN-A-343). J Pharmacol Exp Ther 157, 337-345.
148. Jones, A. (1963). Ganglionic actions of muscarinic substances. J Pharmacol Exp Ther 141, 195-205.
149. Jovanovic-Micic, D., Strbac, M., Krstic, S. K., Japundzic, N., Samardzic, R., & Beleslin, B. D. (1989). Ablation of the area postrema and emesis. Metab Brain Dis 4, 55-60.
150. Jumblatt, J. E., & Hackmiller, R. C. (1994). M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris-ciliary body. Exp Eye Res 58, 175-180.
151. Kakehata, S., Nakagawa, T., Takasaka, T., & Akaike, N. (1993). Cellular mechanism of Ach-induced response in dissociated outer hair cells of guinea-pig cochlea. J Physiol 463, 227-244.
152. Kan, H., Ruan, Y., &Malik, K. U. (1996). Localization and characterization of the subtype(s) of muscarinic receptor involved in prostacyclin synthesis. J Pharmacol Exp Ther 276, 934-941.
153. Karaalp, A., Akici, A., Akbulut, H., Ulusoy, N. B., & Oktay, Ş. (1999). Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria. Pharmacol Res 39, 389-395.
154. Kenakin, T. P. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev 36, 165-222.
155. Kim, J. H., & Ro, Y. B. (1996). Role of muscarinic receptors in ganglionic transmission in rabbits. J Auton Nerv Syst 56, 201-206.
156. Kitazawa, T., Uchiyama, F., Hirose, K., & Taneike, T. (1999). Characterization of the muscarinic receptor subtype that mediates the contractile response of Ach in the swine myometrium. Eur J Pharmacol 367, 325-334.
157. Kleveland, P. M., Waldum, H. L., & Larsson, H. (1987). Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion. Scand J Gastroenterol 22, 705-713.
158. Kondo, T., Nakajima, M., Teraoka, H., Unno, T., Komori, S. -I., Yamada, M., et al. (2011). Muscarinic receptor subtypes involved in regulation of colonic motility in mice: functional studies using muscarinic receptor-deficient mice. Eur J Pharmacol 670, 236-243.
159. Kortezova, N. I., Shikova, L. I., Milusheva, E. A., Itzev, D. E., Bagaev, V. A., & Mizhorkova, Z. N. (2004). Muscarinic modulation of nitrergic neurotransmission in guinea-pig gastric fundus. Neurogastroenterol Motil 16, 155-165.
160. Koss, M. J., & Wally, J. R. (1995). Analysis of miosis produced by McN-A-343 in anaesthetized cats. J Ocul Pharmacol Ther 11, 389-399.
161. Kow, L. -M., Tsai, Y. -F., Weiland, N. G., McEwen, B. S., & Pfaff, D.
162. B receptors. Neurobiol Learn Mem 85, 153-163.
163. Kromer, W., Baron, E., Beinborn, M., Boer, R., & Eltze, M. (1990). Characterization of the muscarinic receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach. Naunyn Schmiedebergs Arch Pharmacol 341, 165-170.
164. Kromer,W., Baron, E., Beinborn,M., Eltze,M., & Simon,W. A. (1989). Stimulation byMcNA-343 and blockade by telenzepine of acid secretion in themouse isolated stomach at histamine-liberating cells. Naunyn Schmiedebergs Arch Pharmacol 340, 68-75.
165. Krstic, M. K. (1980). Analysis of the cardiovascular responses to McN-A-343 and DMPP in pithed guinea-pigs. Neuropharmacology 19, 1113-1118.
166. Kucera, J., & Smith, C. M. (1972). Stimulant action of 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343) on muscle spindles in the rat. Eur J Pharmacol 18, 287-290.
167. ++ responses in cultured urothelial cells from the rat. Am J Physiol Renal Physiol 294, F971-F981.
168. Kvaltinová, Z., Lukoviè, L., Machová, J., & Fatranská, M. (1991). Effect of the steroid alkaloid buxaminol-E on blood pressure, Achsterase activity and (3H)quinuclidinyl benzilate binding in cerebral cortex. Pharmacology 43, 20-25.
169. Ladinsky, H., Giraldo, E., Monferini, E., Schiavi, G. B., Viganò, M. A., De Conti, L., et al. (1988). Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116. Trends Pharmacol Sci 9, 44-48 (Suppl. Subtypes of Muscarinic Receptors III).
170. Lambrecht, G., Gross, J., Hacksell, U., Hermanni, U., Hildebrandt, C., Ilou, X., et al. (1995). The design and pharmacology of novel selective muscarinic agonists and antagonists. Life Sci 56, 815-822.
171. Lambrecht, G., Moser, U., Grimm, U., Pfaff, O., Hermanni, U., Hildebrandt, C., et al. (1993). New functionally selective muscarinic agonists. Life Sci 52, 481-488.
172. Lambrecht, G., Moser, U., Mutschler, E., Walther, G., & Wess, J. (1986). Muscarinic ganglionic stimulants: conformationally restrained analogues related to [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. J Med Chem 29, 1309-1311.
173. Lazareno, S., Farries, T., & Birdsall, N. J. M. (1993). Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci 52, 449-456.
174. 4 muscarinic acetylcholine receptor. Mol Pharmacol 79, 855-865.
175. 4 muscarinic Ach receptor allosteric modulator with potential antipsychotic properties. Neuropsychopharmacology 35, 855-869.
176. Leppik, R. A., Miller, R. C., Eck, M., & Pacquet, J. -L. (1994). Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic Ach receptor. Mol Pharmacol 45, 983-990.
177. Leung, E., & Mitchelson, F. (1982a). The interaction of pancuronium with cardiac and ileal muscarinic receptors. Eur J Pharmacol 80, 1-9.
178. Leung, E., & Mitchelson, F. (1982b). Modification by hexamethonium of the muscarinic receptor blocking activity of pancuronium and homatropine in isolated tissues of the guinea-pig. Eur J Pharmacol 80, 11-17.
179. Li, C. G., & Rand, M. J. (1989). Prejunctional inhibition of non-adrenergic noncholinergic transmission in the rat anococcygeus muscle. Eur J Pharmacol 168, 107-110.
180. Li, Y., Wu, X., Zhu, J., Yan, J., & Owyang, C. (2003). Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. J Physiol 552, 571-587.
181. Lin, Y., & Phyllis, J. W. (1991a). Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex. Eur J Pharmacol 200, 45-52.
182. Lin, Y., & Phyllis, J. W. (1991b). Muscarinic agonist oxotremorine-M-induced long-term depression in rat cerebral cortex. Brain Res Bull 27, 115-117.
183. Lin, Y., & Phyllis, J. W. (1991c). Muscarinic agonist-mediated induction of long-term potentiation in rat cerebral cortex. Brain Res 551, 342-345.
184. 2+ channels in cultured sphenopalatine ganglion: direct evidence for Ach inhibition of cerebral nitrergic neurogenic vasodilation. J Pharmacol Exp Ther 302, 397-405.
185. Liu, C., & Gillette, M. U. (1996). Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. J Neurosci 16, 744-751.
186. 3 receptors. Brain Res 805, 220-233.
187. Liu, J., & Lee, T. J. F. (1999). Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in cerebral arteries. Am J Physiol 276, H194-H204
188. (Heart Circ 45) .
189. Lograsso, M., Nadeson, R., & Goodchild, C. S. (2002). The spinal antinociceptive effects of cholinergic drugs in rats: receptor subtype specificity in different nociceptive tests. BMC Pharmacol 2, 20 (no last page as online journal).
190. Marks, G. A., & Roffwarg, H. P. (1991). Cholinergic modulation of responses to glutamate in the thalamic reticular nucleus of the anesthetized rat. Brain Res 557, 48-56.
191. Marks, G. A., & Roffwarg, H. P. (1993). Cholinergic responsiveness of neurons in the ventroposterior thalamus of the anaesthetized rat. Neuroscience 54, 391-400.
192. 1-subtype. Br J Pharmacol 98, 557-573.
193. 1 receptor agonist MCN-A-343 in the conscious rat. Life Sci 59, 1839-1852.
194. Martin, J. R. (1996b). McN-A-343 increases renal sympathetic nerve activity and blood pressure by a muscarinic and a non-muscarinic mechanism in the rat. J Auton Pharmacol 16, 281-292.
195. 2α muscarinic receptor antagonist, does not inhibit Cch-induced drinking in the rat. Eur J Pharmacol 163, 387-391.
196. Masuda, Y., Yamahara, N. S., Tanaka, M., Ryang, S., Kawai, T., Imaizumi, Y., et al. (1995). Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle. Br J Pharmacol 114, 769-776.
197. 1 muscarinic receptor subtype and is antagonized by McN-A-343. Brain Res 585, 307-310.
198. 2 muscarinic receptors. Mol Pharmacol 39, 359-363.
199. Matsuno, K., & Mita, S. (1992). Involvement of the muscarinic receptors in the postsynaptic potentiation of neurogenic twitch contraction in the mouse vas deferens. Life Sci 50, 799-806.
200. 2 muscarinic Ach receptors. Mol Pharmacol 72, 463-476.
201. McKinney, M., Stenstrom, S., & Richelson, E. (1985). Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mol Pharmacol 27, 223-235.
202. 1 muscarinic receptor in transfected murine fibroblast cells (B82). J Pharmacol Exp Ther 256, 689-694.
203. Mellin, C., Vargas, H. M., & Ringdahl, B. (1989). Dimethylsulfonium analogues of the muscarinic agent McN-A-343: [4-[[N-(3- or 4-halophenyl) carbamoyl]oxy]-2-butynyl] dimethylsulfonium perchlorates. J Med Chem 32, 1590-1593.
204. 1 muscarinic receptors. J Pharmacol Exp Ther 253, 310-314.
205. Micheletti, R., Schiavone, A., & Giachetti, A. (1988). Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J Pharmacol Exp Ther 244, 680-684.
206. Miranda, H. F., Duran, E., Bustamante, D., Paeile, C., & Pinardi, G. (1994). Pre- and postjunctional muscarinic receptor subtypes in the vas deferens of rat. Gen Pharmacol 25, 1643-1647.
207. Miranda, H. F., Duran, E., Fernandez, E., & Pinardi, G. (1995). Muscarinic receptor sub-types in the bisected vas deferens of the rat. Gen Pharmacol 26, 387-391.
208. Mitchelson, F. (1971).Differentiation between the actions of Ach and tetramethylammonium on the isolated taenia of the guinea-pig caecum by hemicholinium-3. Br J Pharmacol 42, 43-55.
209. 2 receptors in smooth muscle. Proc West Pharmacol Soc 42, 109-110.
210. Mori, M., Tsushima, H., Kamiya, T., & Matsuda, T. (1994). Effects of muscarinic receptor modulators in the hypothalamic supraoptic nucleus of the rat. Jpn J Pharmacol 66, 413-419.
211. Moriya, H., Takagi, Y., Nakanishi, T., Hayashi, M., Tani, T., & Hirotsu, I. (1999). Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci 64, 2351-2358.
212. Moroi-Fetters, S. E., Neff, N. H., & Hadjiconstantinou, M. (1988). Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina. J Pharmacol Exp Ther 246, 553-557.
213. Nabekura, J., Ebihara, S., & Akaike, N. (1993). Muscarinic receptor activation of potassium channels in rat dentate gyrus neurons. J Neurophysiol 70, 1544-1552.
214. Naguib, M., & Yaksh, T. L. (1997). Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 85, 847-853.
215. 2 muscarinic receptor activation. Heart Vessels 12, 179-191.
216. 4 muscarinic Ach receptor: identification of ligand-specific and global activation mechanisms. J Biol Chem 285, 19012-19021.
217. 4 muscarinic Ach receptors gained using a novel allosteric modulator and a DREADD (Designer receptor exclusively activated by a designer drug). Mol Pharmacol 74, 1119-1131.
218. Nedergaard, O. (1980). Modulation by the muscarinic agonist McN-A-343 of noradrenaline release from vascular sympathetic neurons. J Cardiovasc Pharmacol 2, 629-643.
219. Nelson, W. L., Freeman, D. S., & Vincenzi, F. F. (1976a). Stereochemical analogs of a muscarinic ganglion stimulant, 2. Cis and trans olefinic, epoxide, and cyclopropane analogs related to 4-[N-(3-chlorophenyl) carbamoyloxy]-2-butynyltrimethylammonium chloride (McN-A-343). J Med Chem19, 153-158.
220. Nelson, W. L., Freeman, D. S., & Vincenzi, F. F. (1976b). Stereochemical analogs of a muscarinic ganglion stimulant, 3. 2,3-Substituted bicyclo(2.2.1)hept-5-enes and - heptanes related to 4-(N-(3-chlorophenyl) carbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343). J Med Chem 19, 159-160.
221. Némethy, Z., Makara, G. B., & Ács, Z. (1999). Effect of cholinergic drugs on the concentration of intracellular free calcium of rat pituitary intermediate lobe cells. Brain Res Bull 50, 53-57.
222. Nilsson, B. M., Vargas, H. M., & Hacksell, U. (1992). Amide, urea and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl] oxy]-2-butynyl]trimethylammonium chloride. J Med Chem 35, 2787-2798.
223. Nishikawa, M., Munakata, M., & Akaike, N. (1994). Muscarinic Ach response in pyramidal neurons of rat cerebral cortex. Br J Pharmacol 112, 1160-1166.
224. Nittykoski, M., Ruotsalainen, S., Haapalinna, A., Larson, J., & Sirvio, J. (1999). Activation of muscarinic M3-like receptors and β-adrenoceptors, but not M2-like muscarinic receptors or α-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro. Neuroscience 90, 95-105.
225. 3 muscarinic receptors in human pulmonary arteries. Br J Pharmacol 119, 149-157.
226. 2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J Physiol 368, 435-452.
227. O'Gara, B. A., Abbasi, A., Kaniecki, K., Sarder, F., Liu, J., & Narine, L. H. (1999). Pharmacological characterization of the response of the leech pharynx to Ach. J Exp Zool 284, 729-741.
228. - secretion in rat colonic epithelia. Eur J Pharmacol 275, 83-89.
229. Okamoto, H., Prestwich, S. A., Asai, S., Unno, T., Bolton, T. B., & Komori, S. (2002). Muscarinic agonist potencies at three different effector systems linked to the M2 or M3 receptor in longitudinal smooth muscle of guinea-pig small intestine. Br J Pharmacol 135, 1765-1775.
230. Okamoto, H., Unno, T., Arima, D., Suzuki, M., Yan, H. -D., Matsuyama, H., et al. (2004). Phospholipase C involvement in activation of the muscarinic receptor-operated cationic current in guinea pig ileal smooth muscle cells. J Pharmacol Sci 95, 203-213.
231. 4 receptors in guinea-pig gallbladder smooth muscle. J Auton Pharmacol 18, 195-204.
232. 1 muscarinic receptor activation in the rat small intestine. Br J Pharmacol 127, 309-313.
233. 4 ligand muscarinic toxin 3 (MT3). Br J Pharmacol 118, 283-288.
234. 4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3. Eur J Pharmacol 357, 235-242.
235. Olianas, M. C., & Onali, P. (1991a). Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity. J Pharmacol Exp Ther 259, 673-679.
236. Olianas, M. C., & Onali, P. (1991b). Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart. J Pharmacol Exp Ther 259, 680-686.
237. 1 receptors on rat motoneurons. Neurosignals 14, 262-272.
238. 1 receptors at the rat motor endplate. Neurosci Lett 459, 127-131.
239. Owen, D. A. A. (1971). Responses to pressor substances in conscious and anaesthetized cats. Br J Pharmacol 43, 668-670.
240. 4 subtype. Pharmacology 46, 308-314.
241. Pappano, A. J., & Rembish, R. A. (1971). Negative chronotropic effects of McN-A-343 and nicotine in isolated guinea-pig atria: insensitivity to blockade by tetrodotoxin. J Pharmacol Exp Ther 177, 40-47.
242. Pavlov, V. A., Ochani, M., Gallowitsch-Puerta, M., Ochani, K., Huston, J. M., Czura, C. J., et al. (2006). Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci U S A 103, 5219-5223.
243. 2 receptor subtype. Eur J Pharmacol 125, 63-70.
244. Pfaffendorf, M., & Van Zwieten, P. A. (1993). Mediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal vein. Br J Pharmacol 108, 132-138.
245. 2 receptors. Am J Physiol 254, G622-G629
246. (Gastrointest. Liver Physiol. 17).
247. Pisani, A., Gubellini, P., Bonsi, P., Conquet, F., Picconi, B., Centonze, D., et al. (2001). Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience 106, 579-587.
248. Pittel, Z., Heldman, E., Rubinstein, R., & Cohen, S. (1990). Distinct muscarinic receptor subtypes differentially modulate Ach release from corticocerebral synaptosomes. J Neurochem 55, 665-672.
249. Pittel, Z., Heldman, E., Rubinstein, R., & Cohen, S. (1992). Inhibition of choline efflux results in enhanced Ach synthesis and release from in the guinea-pig corticocerebral synaptosomes. Neurochem Int 20, 219-227.
250. Przyborski, S. A., & Levin, R. J. (1997). Cholinergic modulation of electrogenic ion transport in different regions of the rat small intestine. J Pharm Pharmacol 49, 691-697.
251. Psarropoulou, C., Beaucher, J., & Harnois, C. (1998). Comparison of the effects of M1 and M2 receptor activation in the absence of GABAergic inhibition in immature rat hippocampal CA3 area. Dev Brain Res 107, 285-290.
252. Pujol Lereis, V. A., Hita, F. J., Gobbi, M. D., Verdi, M. G., Rodriguez, M. C., & Rothlin, R. P. (2006). Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein. Br J Pharmacol 147, 516-523.
253. 2 receptor subtype selective drugs modulate neocortical EEG via thalamus. Neruroreport 9, 1685-1689.
254. Rand, M. J., & Varma, B. (1971). Effects of the muscarinic agonist McN-A-343 on responses to sympathetic nerve stimulation in the rabbit ear artery. Br J Pharmacol 43, 536-542.
255. 2 muscarinic drugs on septohippocampal, hippocampal and cortical neurons in the rat. Brain Res 446, 303-313.
256. Reid, M. S., Nishino, S., Tafti, M., Siegel, J. M., Dement, W. C., & Mignot, E. (1998). Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines. Exp Neurol 151, 89-104.
257. Reid, M. S., Tafti, M., Nishino, S., Siegel, J. M., Dement, W. C., & Mignot, E. (1994). Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors. Sleep 17, 424-435.
258. Ren, L. -M., Nakane, T., & Chiba, S. (1993). Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J Cardiovasc Pharmacol 22, 841-846.
259. Rhee, J. C., Rhee, P. L., Park, M. K., So, I., Uhm, D. Y., Kim, K. W., et al. (2000). Muscarinic receptors controlling the Cch-activated nonselective cation current in guinea pig gastric smooth muscle cells. Jpn J Pharmacol 82, 331-337.
260. Richards, M. H. (1990). Relative potencies of agonists and differential sensitivity to Nethylmaleimide on muscarinic autoreceptors and postsynaptic receptors in rat hippocampus. J Pharmacol Exp Ther 255, 83-89.
261. Richards, M. H., & van Giersbergen, P. L. M. (1995). Human muscarinic receptor expressed in A9L and CHO cells: activation by full and partial agonists. Br J Pharmacol 114, 1241-1249.
262. Ringdahl, B., Mellin, C., Ehlert, F. J., Roch, M., Rice, K. M., & Jenden, D. J. (1990). Tertiary 2-haloethylamine derivatives of the muscarinic agent McN-A-343, [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl] trimethylammonium chloride. J Med Chem 33, 281-286.
263. Roszkowski, A. P. (1961). An unusual type of sympathetic ganglion stimulant. J Pharmacol Exp Ther 132, 156-170.
264. Roszkowski, A. P., & Yelnosky, J. (1967). Structure-activity relationships among a series of acetylenic carbamates related to McN-A-343. J Pharmacol Exp Ther 156, 238-245.
265. Rowbotham, H., Jury, J., & Daniel, E. E. (1985). Capsaicin effects on muscularis mucosa of opossum esophagus: substance P release from afferent nerves? Am J Physiol 248, G655-G662 (Gastrointest Liver Physiol).
266. Rubanyi, G. M., McKinney, M., & Vanhoutte, P. M. (1987). Biphasic release of endothelium-derived relaxing factor(s) by Ach from perfused canine femoral arteries. Characterization of muscarinic receptors. J Pharmacol Exp Ther 240, 802-808.
267. Rubinstein, R., & Cohen, S. (1992). Lack of agonist activity in McN-A343 may be circumstantial. J Auton Pharmacol 12, 1-4.
268. Säfsten, B., Jedstedt, G., & Flemström, G. (1994). Cholinergic influence on duodenal mucosal bicarbonate secretion in the anesthetized rat. Am J Physiol 267, G10-G17
269. (Gastrointest liver physiol 30).
270. Sagrada, A., Schiavi, G. B., Cereda, E., & Ladinsky, H. (1994). Antagonistic properties of McNeil-A-343 at 5-HT4 and 5-HT3 receptors. Br J Pharmacol 113, 711-716.
271. 4 receptor. Neurochem Res 34, 1363-1371.
272. Sanchez-Andrés, J. V., & Soria, B. (1991). Muscarinic inhibition of pancreatic B- cells. Eur J Pharmacol 205, 89-91.
273. 3H]-cyclic AMP accumulation in rat striatal slices. Neurochem Res 31, 555-561.
274. Sandvik, A. K., Kleveland, P. M., & Waldum, H. L. (1987). Stimulated pepsin secretion after omeprazole-induced acid suppression in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol 22, 362-366.
275. Sanz, B., Exposito, I., & Mora, F. (1997). M1 Ach receptor stimulation increases the extracellular concentrations of glutamate and GABA in the medial prefrontal cortex of the rat. Neurochem Res 22, 281-286.
276. Satoh, S., Taira, N., & Hashimoto, K. (1973). Absence of a neurally-mediated process in salivation and vasodilation caused by McN-A-343 in the dog submaxillary gland. Jpn J Pharmacol 23, 581-583.
277. Sawyer, B. D., Bymaster, F. P., Calligaro, D. O., Falcone, J., Mitch, C. H., Ward, J. S., et al. (1999). Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta. Gen Pharmacol 32, 445-452.
278. Schaafsma, D., Boterman, M., de Jong, A. -M., Hovens, I., Penninks, J. -M., Nelemans, S. A., et al. (2006). Differential Rho-kinase dependency of full and partial muscarinic receptor agonists in airway smooth muscle contraction. Br J Pharmacol 147, 737-743.
279. Schiavone, A., Sagrada, A., Micheletti, R., & Giachetti, A. (1988). Pharmacological characterization of muscarinic receptors involved in McN-A-343-induced effects on intestinal motility and heart rate in conscious dogs. Br J Pharmacol 94, 566-572.
280. Schoffelmeer, A. N. M., Hogenboom, F., & Mulder, A. H. (1988). M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors. J Pharmacol Exp Ther 245, 658-663.
281. Schuurkes, J. A. J., Van Bergen, P. J. E., & Van Nueten, J. M. (1988). Prejunctional muscarinic (M1)-receptor interactions on guinea-pig ileum: lack of effect of cisapride. Br J Pharmacol 94, 228-234.
282. Schwörer, H., Racké, K., & Kilbinger, H. (1989). Characterization of the muscarinic receptors involved in the modulation of serotonin release from the vascularly perfused small intestine of guinea pig. Naunyn Schmiedebergs Arch Pharmacol 339, 263-267.
283. 2+ channels in neurons of the major pelvic ganglion of the adult male rat. Neurochem Res 26, 933-942.
284. 1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens. Eur J Pharmacol 232, 45-57.
285. 4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist and antagonist classes. Neurochem Res 20, 669-674.
286. Shen, A., & Mitchelson, F. (1998). Muscarinic M2 receptor-mediated contraction in the guinea pig taenia caeci: possible involvement of protein kinase C. Biochem Pharmacol 56, 1529-1537.
287. 1 when endothelium is intact. Am J Physiol 264, H665-H669
288. (Heart Circ Physiol 33) .
289. Shirvan, M. H., Pollard, H. B., & Heldman, E. (1991). Mixed nicotinic and muscarinic features of cholinergic receptor coupled to secretion in bovine chromaffin cells. Proc Natl Acad Sci U S A 88, 4860-4864.
290. Simioni, L. R., Corrado, A. P., & Jurkiewicz, A. (1976). A comparative study of the effects induced by MCN-A-343 and Ach on the isolated toad rectus abdominis. Gen Pharmacol 7, 127-132.
291. Simioni, L. R., Fontana, M. O., Prado, W. A., & Corrado, A. P. (1984). Pre- and postsynaptic actions of McN-A-343 in the neuromuscular junction: myographic and electrophysiologic studies in vitro. Gen Pharmacol 15, 559-562.
292. Simonsen, U., Prieto, D., Rivera, L., Hernández, M., Mulvany, M. J., & García-Sacristán, A. (1993). Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries. Br J Pharmacol 109, 998-1007.
293. Smith, J. C. (1966a). Observations on the selectivity of stimulant action of 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammoniumchloride on sympathetic ganglia. J Pharmacol Exp Ther 153, 266-275.
294. Smith, J. C. (1966b). Pharmacological interactions with 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammoniumchloride, a sympathetic ganglion stimulant. J Pharmacol Exp Ther 153, 276-284.
295. Somogyi, G. T., & de Groat, W. C. (1992). Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder. J Auton Nerv Syst 37, 89-97.
296. 3H]Ach in the major pelvic ganglion of the rat. Am J Physiol 264, R1084-R1088
297. (Reg Integ Comp Physiol 33).
298. Spalding, T. A., Burstein, E. S., Brauner-Osborne, H., Hill-Eubanks, D., & Brann, M. R. (1995). Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. J Pharmacol Exp Ther 275, 1274-1279.
299. Stein, R., Bachoo, M., & Polosa, C. (1995). Pirenzepine-sensitive component of forelimb vascular resistance and heart rate in cats. J Auton Nerv Syst 54, 49-58.
300. 3 receptor knockout mice. J Pharmacol Exp Ther 304, 675-682.
301. Stewart, B. R., Jenner, P., & Marsden, C. D. (1989). Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour. Psychopharmacology 97, 228-234.
302. 2 muscarinic receptor using its nitrogen mustard derivative. Biochem Pharmacol 79, 1025-1035.
303. Suga, H., Sawyer,G.W., & Ehlert, F. J. (2010).Mutagenesis of nucleophilic residues near the orthosteric binding pocket ofM1 andM2muscarinic receptors: effect on the binding of nitrogen mustard analogs of Ach and McN-A-343. Mol Pharmacol 78, 745-755.
304. Szekeres, P. G., Koenig, J. A., & Edwardson, J. M. (1998). The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line. Mol Pharmacol 53, 759-765.
305. Taira, N., Matsumura, S., & Hashimoto, K. (1968). Excitation of the parasympathetic ganglia of the canine urinary bladder by a muscarinic ganglion stimulant, 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343). Tohoku J Exp Med 96, 209-210.
306. Taira, N., Matsumura, S., & Hashimoto, K. (1971). Excitation of the parasympathetic ganglia of the canine urinary bladder through a muscarinic mechanism. J Pharmacol Exp Ther 176, 93-100.
307. 3 receptor in guinea pig gallbladder. Am J Physiol 267, G523-G528
308. (Gastrointest Liver Physiol 30).
309. Thomas, E. A., Baker, S. A., & Ehlert, F. J. (1993). Functional role for the M2 muscarinic receptor in smooth muscle of the guinea pig ileum. Mol Pharmacol 44, 102-110.
310. Threlfell, S., Clements, M. A., Khodai, T., Pienaar, I. S., Exley, R., Wess, J., et al. (2010). Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30, 3398-3408.
311. Tobin, G., & Sjögren, C. (1998). Prejunctional facilitatory and inhibitory modulation of parasympathetic nerve transmission in the rabbit urinary bladder. J Auton Nerv Syst 68, 153-156.
312. Tomic-Beleslin, N., & Beleslin, D. B. (1986). Salivation mediated by central M-2 muscarinic receptors in the cat. Brain Res Bull 17, 279-281.
313. Tong, Y. -C., Hung, Y. -C., Lin, S. -N., & Cheng, J. -T. (1997). Pharmacological characterization of the muscarinic receptor subtypes responsible for the contractile response in the rat urinary bladder. J Auton Pharmacol 17, 21-25.
314. 3 muscarinic receptors. Mol Pharmacol 75, 381-396.
315. Trendelenburg, U. (1956). Modification of transmission through superior cervical ganglion of cat. J Physiol 132, 529-541.
316. Trendelenburg, U. (1959). Non-nicotinic ganglion-stimulating substances. Fed Proc 18, 1001-1005.
317. Tumiatti, V., Angeli, P., Andrisano, V., Bolognesi, M. L., Cavalli, A., Marucci, G., et al. (2000). [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]- trimethylammonium (McN-A-343)-related compounds. Effect of the butynyl chain inclusion into an aromatic unit on the potency for muscarinic receptors. Bioorg Med Chem 8, 681-689.
318. Unno, T., Kwon, S. -C., Okamoto, H., Irie, Y., Kato, Y., Matsuyama, H., et al. (2003). Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle. Br J Pharmacol 139, 337-350.
319. Unno, T., Matsuyama, H., Okamoto, H., Sakamoto, T., Yamamoto, M., Tanahashi, Y., et al. (2006). Muscarinic cationic current in gastrointestinal smooth muscles: signal transduction and role in contraction. Auton Autacoid Pharmacol 26, 203-217.
320. 3 muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice. Br J Pharmacol 146, 98-108.
321. Valant, C., Gregory, K. J., Hall, N. E., Scammells, P. J., Lew, M. J., Sexton, P. M., et al. (2008). A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand. J Biol Chem 283, 29312-29321.
322. Van Charldorp, K. J., de Jonge, A., Thoolen, M. J. M. C., & van Zwieten, P. A. (1985). Sub-classification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists. Naunyn Schmiedebergs Arch Pharmacol 331, 301-306.
323. Van Giersbergen, P. L. M., & Leppik, R. (1995). Modulation of agonist binding by guanine nucleotides in CHO cells expressing muscarinic m1-m5 receptors. Naunyn Schmiedebergs Arch Pharmacol 352, 166-172.
324. Van Rossum, J. M., Hurkmans, J. A. Th. M., Jetten, M., van Ras, M., & Th, J. (1962a). Classification and molecular pharmacology of ganglionic blocking agents. Part II. Mode of action of competitive and non-competitive ganglion blocking agents. Int J Neuropharmacol 1, 403-421.
325. Van Rossum, J. M., van Ras, M., Th, J., Hurkmans, J. A. Th. M., & Hylkema, M. J. Th. (1962b). Classification and molecular pharmacology of ganglionic blocking agents. Part I. Mechanism of ganglionic synaptic transmission and mode of action of ganglionic stimulants. Int J Neuropharmacol 1, 97-110.
326. Verbitsky, M., Rothlin, C. V., Katz, E., & Elgoyhen, A. B. (2000). Mixed nicotinic-muscarinic properties of the α9 nicotinic cholinergic receptor. Neuropharmacology 39, 2515-2524.
327. Vizi, E. S., Kobayashi, O., Töro{combining double acute accent}csik, A., Kinjo, M., Nagashima, H., Manabe, N., et al. (1989). Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release. Neuroscience 31, 259-267.
328. 5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors. Mol Pharmacol 64, 21-31.
329. Von Schrenck, T., Mackensen, B., Mende, U., Schmitz, W., Sievers, J., Mirau, S., et al. (1994). Signal transduction pathway of the muscarinic receptors mediating gallbladder contraction. Naunyn Schmiedebergs Arch Pharmacol 349, 346-354.
330. Von Schrenck, T., Sievers, J., Mirau, S., Raedler, A., & Greten, H. (1993). Characterization of muscarinic receptors on guinea pig gallbladder smooth muscle. Gastroenterology 105, 1341-1349.
331. Vong, Y.M. (1985). Characterization of muscarinic receptors. M. Pharm. Thesis, Victorian College of Pharmacy, Melbourne, Australia.
332. Waelbroeck, M. (1994). Identification of drugs competing with D-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol 46, 685-692.
333. 1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla. Life Sci 39, 2073-2080.
334. Walker, S. W., Strachan, M. W. J., Lightly, E. R. T., Williams, B. C., & Bird, I. M. (1990). Ach stimulates cortisol secretion through the M3 muscarinic receptor linked to a polyphosphoinositide-specific phospholipase C in bovine adrenal fasciculata/reticularis cells.Mol Cell Endocrinol 72, 227-238.
335. Wall, P. M., Flinn, J., & Messier, C. (2001). Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice. Psychopharmacology 155, 58-68.
336. Wallis, R. M., & Napier, C. M. (1999). Muscarinic antagonists in development for disorders of smooth muscle function. Life Sci 64, 395-401.
337. Wang, S. Z., & El-Fakahany, E. E. (1993). Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J Pharmacol Exp Ther 266, 237-243.
338. Wang, S. Z., Zhu, S. Z., & El-Fakahany, E. E. (1994). Efficient coupling of m5 muscarinic Ach receptors to activation of nitric oxide synthase. J Pharmacol Exp Ther 268, 552-557.
339. Watson, N., Reddy, H., & Eglen, R. M. (1995). Pharmacological characterization of the muscarinic receptors mediating contraction of canine saphenous vein. J Auton Pharmacol 15, 437-441.
340. 3H] quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. 1. Characterization and regulation of agonist binding to putative muscarinic subtypes. J Pharmacol Exp Ther 237, 411-418.
341. Weill, C., Galzi, J. -L., Chasserot-Golaz, S., Goeldner, M., & Ilien, B. (1999). Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors. J Neurochem73, 791-801.
342. Weiser, M., Mutschler, E., & Lambrecht, G. (1997). Characterization of postganglionic muscarinic receptors mediating contraction in rat anococcygeus muscle. Naunyn Schmiedebergs Arch Pharmacol 356, 671-677.
343. Welsh, N. J., Shankley, N. P., & Black, J. W. (1995). Application of a model to explore interspecies differences in Ach M-receptor-stimulated gastric acid secretion. Br J Pharmacol 115, 961-968.
344. Wess, J. (2004). Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 44, 423-450.
345. Wess, J., Lambrecht, G., Moser, U., & Mutschler, E. (1984). A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the rat. Life Sci 35, 553-560.
346. Wilffert, B., Davidesko, D., Timmermans, P. B. M. W. M., & van Zwieten, P. A. (1983). Differential role of M-1 and M-2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha adrenoceptor-mediated vasoconstriction. J Pharmacol Exp Ther 226, 855-860.
347. Williams, P. D., Colbert, W. E., Shetler, T. J., & Turk, J. A. (1992). Comparative pharmacological profile of muscarinic agonists in the isolated ileum, the pithed rat and the mouse charcoal meal transit test. Gen Pharmacol 23, 177-185.
348. Williams, S. H., & Constanti, A. (1988a). Quantitative effects of some muscarinic agonists on evoked surface-negative field potentials recorded from the guinea-pig olfactory cortex slice. Br J Pharmacol 93, 846-854.
349. Williams, S. H., & Constanti, A. (1988b). A quantitative study of the effects of some muscarinic antagonists on the guinea-pig olfactory cortex slice. Br J Pharmacol 93, 855-862.
350. Wilson, P. S., Khimenko, P. L., Barnard, J. W., Morre, T. M., & Taylor, A. E. (1995). Muscarinic agonists and antagonists cause vasodilation in isolated rat lung. J Appl Physiol 78, 1404-1411.
351. 5 muscarinic receptors stimulate mitogen-activated protein kinase. Pharmacology 56, 175-186.
352. Xi-Moy, S. X., Randall, W. C., & Wurster, R. D. (1993). Nicotinic and muscarinic synaptic transmission in canine intracardiac ganglion cells innervating the sinoatrial node. J Auton Nerv Syst 42, 201-214.
353. Xu, M., Yamamoto, T., & Kato, T. (1990). In vivo striatal dopamine release by M1 muscarinic receptors is induced by activation of protein kinase C. J Neurochem 54, 1917-1919.
354. Yang, J. -J., Wang, Y. -T., Cheng, P. -C., Kuo, Y. -J., & Huang, R. -C. (2010). Cholinergic modulation of neuronal excitability in the rat suprachiasmatic nucleus. J Neurophysiol 103, 1397-1409.
355. Zhang, W., Basile, A. S., Gomeza, J., Volpicelli, L. A., Levey, A. I., & Wess, J. (2002a). Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 22, 1709-1717.
356. 5 muscarinic receptor knock-out mice. J Neurosci 22, 6347-6352.
357. Zholos, A. V., & Bolton, T. B. (1997). Muscarinic receptor subtypes controlling the cationic current in guinea-pig ileal smooth muscle. Br J Pharmacol 122, 885-893.
358. 3 or DAG, -dependent activation of the muscarinic receptor-operated cation current in guinea-pig ileal smooth muscle cells. Br J Pharmacol 141, 23-36.
359. Zhu, J. J., & Uhlrich, D. J. (1998). Cellular mechanisms underlying two muscarinic receptor-mediated depolarizing responses in relay cells of the rat lateral geniculate nucleus. Neuroscience 87, 767-781.